Benefits of Streamlined Point-of-Care Trial Designs: Lessons Learned From the UK RECOVERY Study

Robert M Califf; Patrizia Cavazzoni; Janet Woodcock

doi:10.1001/jamainternmed.2022.4810

Benefits of Streamlined Point-of-Care Trial Designs: Lessons Learned From the UK RECOVERY Study

JAMA Intern Med. 2022 Dec 1;182(12):1243-1244. doi: 10.1001/jamainternmed.2022.4810.

Authors

Robert M Califf¹, Patrizia Cavazzoni¹, Janet Woodcock¹

Affiliation

¹ US Food and Drug Administration, Silver Spring, Maryland.

PMID: 36279126
DOI: 10.1001/jamainternmed.2022.4810

No abstract available

Plain language summary

This Viewpoint discusses the benefits of streamlined point-of-care trial designs in clinical research, using lessons learned from the UK RECOVERY study of dexamethasone dosing for patients with COVID-19 and hypoxia.

MeSH terms

Clinical Trials as Topic*
Humans
Point-of-Care Systems*
Research Design
United Kingdom